Previous Article | Next Article ![]()
Infect. Immun., 01 1998, 266-271, Vol 66, No. 1
MC Shanafelt, I Kang, SW Barthold and LK Bockenstedt
Recent studies have implicated cytokines associated with Th2 cells in the
genetic resistance to murine Lyme borreliosis. Because the B7/CD28
costimulatory pathway has been shown to influence the differentiation of
Th-cell subsets, we investigated the contribution of the B7 molecules CD80
and CD86 to the Th2 cytokine profile and development of arthritis in BALB/c
mice infected with Borrelia burgdorferi. Effective blockade of CD86/CD28
interaction was demonstrated by elimination of interleukin 4 (IL-4) and
upregulation of gamma interferon (IFN-gamma) responses by B.
burgdorferi-specific T cells and by reduction of B. burgdorferi-specific
immunoglobulin G. Despite the shift toward a Th1 cytokine pattern, which
others have associated with disease susceptibility, the severity of
arthritis was unchanged. Moreover, combined CD80/CD86 blockade by using
anti-CD80 and anti-CD86 monoclonal antibodies or CTLA-4Ig enhanced
IFN-gamma production over that seen with CD86 blockade alone, yet
augmentation of this Th1-associated cytokine did not enhance disease. These
results demonstrate that IL-4 production by T cells in B.
burgdorferi-infected BALB/c mice is dependent upon CD86/CD28 interaction
and that this cytokine does not contribute significantly to host resistance
to the development of arthritis. In addition, combined CD80/CD86 blockade
resulted in preferential expansion of IFN-gamma-producing T cells in B.
burgdorferi infection, suggesting that costimulatory pathways other than
B7/CD28 may contribute to T-cell activation during continuous antigen
stimulation. These studies may provide insight into the role of the B7/CD28
pathway in other infectious and autoimmune diseases in which deviation of
Th cell immune responses occurs and antigen is persistently present.
Copyright © 1998, American Society for Microbiology
Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T- cell costimulatory pathway
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA. Linda.Bockenstedt@Yale.edu
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|